Given that survivin interacts with various cell signaling pathways and growth factors [24], further studies are required to elucidate the interactions among the proteins reduced by FL118 and the subsequent alterations in cancer-related pathways, particularly those related to HR repair. The gene discussed is BIRC5; the disease is cancer.